Tuberculosis is a
debilitating infectious disease that is a
serious health threat, particularly in its
multi-drug-resistant forms. We aim to combine
bioinformatics tools and resources with NMR
structural biology to identify and screen new
drug targets against TB. More than 10% of the world's TB cases are in India. India has a large research community
dedicated to eradicating this disease in
accordance with the WHO objectives, by the
year 2050. TB is a reemerging threat in Europe
but we have downsized the active community
dedicated to TB research.